Cost-utility analysis of vortioxetine versus agomelatine, bupropion SR, sertraline and venlafaxine XR after treatment switch in major depressive disorder in Finland. [electronic resource]
Producer: 20170804Description: 293-302 p. digitalISSN:- 1744-8379
- Acetamides -- administration & dosage
- Antidepressive Agents -- administration & dosage
- Bupropion -- administration & dosage
- Cost-Benefit Analysis
- Decision Trees
- Depressive Disorder, Major -- drug therapy
- Finland
- Humans
- Markov Chains
- Models, Theoretical
- Piperazines -- administration & dosage
- Recurrence
- Sertraline -- administration & dosage
- Sulfides -- administration & dosage
- Treatment Outcome
- Venlafaxine Hydrochloride -- administration & dosage
- Vortioxetine
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.